更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。
米国
- 2025.02.25
- 2025.02.25
February 20, 2025
- Silodosin Capsule (Discontinuation)
February 19, 2025
- Atropine Sulfate Injection (Discontinuation)
- 2025.02.17
- 2025.02.17
February 14, 2025
- Erythromycin Topical Gel (Discontinuation)
February 12, 2025
- Amantadine Hydrochloride Capsule (Discontinuation)
- 2025.02.10
- 2025.02.10
February 7, 2025
- Benazepril Hydrochloride Tablet (Discontinuation)
February 6, 2025
- Glipizide Tablet, Extended Release (Discontinuation)
- Idarubicin Hydrochloride Injection (Discontinuation)
- Varenicline Tartrate Tablet (Discontinuation)
February 5, 2025
- Amantadine Hydrochloride Tablet (Discontinuation)
- Gefitinib Tablet (Discontinuation)
- Pirfenidone Capsule (Discontinuation)
February 4, 2025
- Tretinoin Cream (Discontinuation)
- 2025.02.03
- 2025.02.03
January 30, 2025
- Ramipril Capsule (Discontinuation)
January 28, 2025
- Donepezil Hydrochloride Tablet (Discontinuation)
- LIdocaine Ointment (Discontinuation)
- Lidocaine Ointment (Discontinuation)
- Teriflunomide Tablet (Discontinuation)
January 27, 2025
- Bendamustine Hydrochloride Injection (Discontinuation)
カナダ
カナダの情報はありません。
オーストラリア
- 2025.02.25
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated isosorbide dinitrate Tablet, uncoated 5 mg Anticipated Available Manufacturing 21/02/2025 ciprofloxacin hydrochloride Tablet, film coated 277.5 mg Anticipated Available Manufacturing 21/02/2025 ropinirole hydrochloride Tablet, film coated .57 mg Resolved Available Manufacturing 21/02/2025 trihexyphenidyl (benzhexol) hydrochloride Tablet, uncoated 2 mg Resolved Available Unexpected increase in consumer demand 21/02/2025 risperidone Tablet, film coated 3 mg Current Unavailable Manufacturing 21/02/2025 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 21/02/2025 risperidone Tablet, film coated 2 mg Current Unavailable Manufacturing 21/02/2025 letrozole Tablet, film coated 2.5 mg Anticipated Available Manufacturing 21/02/2025 levetiracetam Tablet, film coated 1000 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 21/02/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Anticipated Available Manufacturing 21/02/2025 olanzapine Tablet, orally disintegrating 5 mg Current Limited Availability Manufacturing 21/02/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 21/02/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 21/02/2025 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Unexpected increase in consumer demand 21/02/2025 sildenafil citrate Tablet, film coated 28.1 mg Anticipated Available Manufacturing 21/02/2025 azithromycin dihydrate Tablet, film coated 524.05 mg Current Unavailable Manufacturing 21/02/2025 quetiapine fumarate Tablet, modified release 460.52 mg Resolved Available Manufacturing 21/02/2025 quetiapine fumarate Tablet, modified release 57.565 mg Anticipated Available Unexpected increase in consumer demand 21/02/2025 metformin hydrochloride Tablet, modified release 1000 mg Discontinued Unavailable Commercial Changes / Commercial viability 21/02/2025 dutasteride Capsule, soft 500 microgram Anticipated Available Manufacturing 21/02/2025 linezolid Tablet, film coated 600 mg Anticipated Available Manufacturing 21/02/2025 ezetimibe Tablet 10 mg Resolved Available Manufacturing 21/02/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 21/02/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 21/02/2025 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 21/02/2025 risperidone Tablet, film coated 2 mg Current Unavailable Manufacturing 21/02/2025 risperidone Tablet, film coated 3 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 21/02/2025 risperidone Tablet, film coated 4 mg Current Unavailable Manufacturing 21/02/2025 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Current Unavailable Manufacturing 21/02/2025 prasugrel Tablet, film coated 5 mg Current Unavailable Manufacturing 21/02/2025 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Anticipated Available Manufacturing 21/02/2025 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Unexpected increase in consumer demand 21/02/2025 gramicidin~framycetin sulfate~dexamethasone Ear Drops .05 mg/mL~5 mg/mL~.5 mg/mL Anticipated Available Manufacturing 21/02/2025 estradiol~dydrogesterone Tablet, film coated 2 mg~10 mg Current Unavailable Manufacturing 21/02/2025 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Resolved Available Manufacturing 21/02/2025 flucloxacillin Injection, powder for 1 g Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 21/02/2025 famotidine Tablet, film coated 20 mg Resolved Available Manufacturing 21/02/2025 mirtazapine Tablet, film coated 30 mg Anticipated Available Manufacturing 21/02/2025 methylphenidate hydrochloride Tablet, modified release 27 mg Current Limited Availability Manufacturing 20/02/2025 amisulpride Tablet 100 mg Current Unavailable Manufacturing 20/02/2025 azithromycin dihydrate Tablet, film coated 524.1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 20/02/2025 mycophenolate mofetil Tablet, film coated 500 mg Current Unavailable Manufacturing 20/02/2025 mirtazapine Tablet, film coated 45 mg Current Unavailable Manufacturing 20/02/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Limited Availability Manufacturing 20/02/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 20/02/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Anticipated Available Manufacturing 20/02/2025 amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil Tablet 6.944 mg~25 mg~40 mg Current Limited Availability Manufacturing 20/02/2025 nicorandil Tablet 10 mg Current Limited Availability Manufacturing 20/02/2025 rizatriptan benzoate Wafer 14.53 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 20/02/2025 tobramycin Injection, solution 40 mg/mL Current Unavailable Unexpected increase in consumer demand 20/02/2025 esomeprazole Capsule, enteric 20 mg Resolved Available Manufacturing 20/02/2025 anastrozole Tablet, film coated 1 mg Current Unavailable Manufacturing 20/02/2025 hydrocortisone Tablet, uncoated 20 mg Current Limited Availability Manufacturing 20/02/2025 mesalazine Tablet, enteric coated 250 mg Current Unavailable Manufacturing 20/02/2025 celecoxib Capsule, hard 100 mg Current Unavailable Manufacturing 20/02/2025 acamprosate calcium Tablet, enteric coated 333 mg Anticipated Available Unexpected increase in consumer demand 20/02/2025 mefenamic acid Capsule, hard 250 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 20/02/2025 buprenorphine Patch, dermal 30 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 20/02/2025 deferasirox Tablet, film coated 90 mg Anticipated Available Manufacturing 20/02/2025 norethisterone acetate~estradiol~estradiol Drug delivery system, transdermal 4.8 mg~.78 mg~.512 mg Current Unavailable Manufacturing 20/02/2025 spironolactone Tablet, uncoated 25 mg Current Limited Availability Manufacturing 20/02/2025 sitagliptin fumarate Tablet, film coated 32.124 mg Current Unavailable Manufacturing 20/02/2025 alprazolam Tablet, uncoated 2 mg Anticipated Available Manufacturing 20/02/2025 Peginterferon alfa2a Injection, solution 135 microgram Anticipated Available Unexpected increase in consumer demand 20/02/2025 Peginterferon alfa2a Injection, solution 180 microgram Anticipated Available Unexpected increase in consumer demand 20/02/2025 citalopram hydrobromide Tablet, film coated 49.96 mg Current Limited Availability Manufacturing 20/02/2025 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Manufacturing 20/02/2025 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Manufacturing 20/02/2025 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Manufacturing 20/02/2025 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 19/02/2025 oxytocin Injection, solution 5 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/02/2025 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 19/02/2025 phenoxymethylpenicillin potassium Tablet, film coated 280 mg Resolved Available Manufacturing 19/02/2025 olmesartan medoxomil~hydrochlorothiazide Tablet 40 mg~25 mg Anticipated Available Manufacturing 19/02/2025 cinacalcet hydrochloride Tablet 99.191 mg Resolved Available Manufacturing 19/02/2025 potassium chloride Injection, concentrated 75 mg/mL Current Unavailable Commercial Changes / Commercial viability 19/02/2025 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 19/02/2025 atorvastatin calcium trihydrate Tablet, film coated 43.376 mg Current Limited Availability Manufacturing 19/02/2025 oxaliplatin Injection, concentrated 100 mg Resolved Available Manufacturing 19/02/2025 nitrofurantoin Capsule, hard 100 mg Anticipated Available Manufacturing 19/02/2025 tamoxifen citrate Tablet, uncoated 15.2 mg Current Limited Availability Manufacturing 19/02/2025 doxycycline hyclate Tablet, film coated 57.5 mg Resolved Available Manufacturing 19/02/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 19/02/2025 bupivacaine hydrochloride Injection, solution 5 mg/mL Resolved Available Manufacturing 18/02/2025 fluorouracil Injection, solution 5000 mg Current Unavailable Unexpected increase in consumer demand 18/02/2025 donepezil hydrochloride Tablet, film coated 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 18/02/2025 amlodipine besilate Tablet 6.93 mg Resolved Available Manufacturing 18/02/2025 cisatracurium besilate Injection, solution 14.07 mg Resolved Available Transport / Logistic issues / Storage capacity issues 18/02/2025 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 18/02/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 18/02/2025 ivabradine hydrochloride Tablet, film coated 8.085 mg Anticipated Available Manufacturing 18/02/2025 ivabradine hydrochloride Tablet, film coated 5.39 mg Anticipated Available Manufacturing 18/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 18/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 18/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 18/02/2025 amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide Tablet, film coated 6.95 mg~40 mg~12.5 mg Anticipated Available Manufacturing 18/02/2025 tenofovir disoproxil succinate~emtricitabine Tablet, film coated 300.6 mg~200 mg Current Unavailable Manufacturing 18/02/2025 mycophenolate sodium Tablet, enteric coated 384.7 mg Resolved Available Manufacturing 18/02/2025 lamotrigine Tablet, chewable 200 mg Current Limited Availability Unexpected increase in consumer demand 18/02/2025 deferasirox Tablet, film coated 360 mg Current Unavailable Manufacturing 18/02/2025 levothyroxine sodium Tablet, uncoated .2 mg Resolved Available Manufacturing 18/02/2025 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 18/02/2025 norethisterone~ethinylestradiol Tablet, uncoated 500 microgram~36 microgram Current Limited Availability Unexpected increase in consumer demand 18/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 18/02/2025 adrenaline (epinephrine) acid tartrate Injection, solution 1.82 mg/mL Current Unavailable Manufacturing 17/02/2025 trihexyphenidyl (benzhexol) hydrochloride Tablet, uncoated 5 mg Current Limited Availability Unexpected increase in consumer demand 17/02/2025 metronidazole Tablet, uncoated 400 mg Anticipated Available Manufacturing 17/02/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 17/02/2025 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 17/02/2025 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 17/02/2025 bicalutamide Tablet, film coated 50 mg Current Unavailable Manufacturing 17/02/2025 quetiapine fumarate Tablet, modified release 172.695 mg Anticipated Available Unexpected increase in consumer demand 17/02/2025 quetiapine fumarate Tablet, film coated 28.78 mg Resolved Available Manufacturing 17/02/2025 candesartan cilexetil Tablet, uncoated 4 mg Current Limited Availability Manufacturing 17/02/2025 escitalopram oxalate Tablet, film coated 25.47 mg Current Limited Availability Manufacturing 17/02/2025 clopidogrel besilate Tablet, film coated 112.1 mg Current Unavailable Manufacturing 17/02/2025 simvastatin Tablet, film coated 10 mg Resolved Available Manufacturing 17/02/2025 simvastatin Tablet, film coated 80 mg Current Unavailable Manufacturing 17/02/2025 morphine hydrochloride trihydrate Injection, solution 20 mg/mL Current Limited Availability Manufacturing 17/02/2025 tadalafil Tablet, film coated 20 mg Resolved Available Manufacturing 17/02/2025 ribociclib succinate Tablet, film coated 254.4 mg Resolved Available Transport / Logistic issues / Storage capacity issues 17/02/2025 lacosamide Tablet, film coated 100 mg Anticipated Available Unexpected increase in consumer demand 17/02/2025 pregabalin Capsule, hard 75 mg Resolved Available Unexpected increase in consumer demand 17/02/2025 famotidine Tablet, film coated 40 mg Current Unavailable Manufacturing 17/02/2025 - 2025.02.17
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated fentanyl Drug delivery system, transdermal 4.2 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 14/02/2025 morphine hydrochloride trihydrate Injection, solution 10 mg/mL Resolved Available Manufacturing 14/02/2025 leuprorelin acetate~bicalutamide Injection, modified release~Tablet, film coated 22.5 mg~50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 14/02/2025 leuprorelin acetate~bicalutamide Injection, modified release~Tablet, film coated 7.5 mg~50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 14/02/2025 leuprorelin acetate~bicalutamide Injection, modified release~Tablet, film coated 22.5 mg~50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 14/02/2025 mupirocin Ointment 20 mg/g Current Limited Availability Unexpected increase in consumer demand 14/02/2025 ethanol absolute~carmustine Diluent, not applicable~Injection, powder for 3 mL~100 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 14/02/2025 tramadol hydrochloride Tablet, modified release 200 mg Resolved Available Manufacturing 13/02/2025 glyceryl trinitrate Injection, concentrated 50 mg Current Limited Availability Manufacturing 13/02/2025 levetiracetam Tablet, film coated 250 mg Resolved Available Manufacturing 13/02/2025 levodopa~entacapone~carbidopa monohydrate Tablet, film coated 125 mg~200 mg~33.75 mg Anticipated Available Manufacturing 13/02/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Anticipated Available Unexpected increase in consumer demand 13/02/2025 daptomycin Injection, powder for 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 13/02/2025 melatonin Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 13/02/2025 heparin sodium Injection, solution 10 IU/mL Current Unavailable Manufacturing 13/02/2025 tobramycin Injection, solution 80 mg Resolved Available Manufacturing 12/02/2025 amlodipine besilate Tablet, uncoated 6.94 mg Resolved Available Manufacturing 12/02/2025 topiramate Tablet, film coated 200 mg Resolved Available Manufacturing 12/02/2025 letrozole Tablet, film coated 2.5 mg Current Unavailable Manufacturing 12/02/2025 vinblastine sulfate Injection, solution 1 mg/mL Current Limited Availability Manufacturing 12/02/2025 oxytocin Injection, solution 10 IU/mL Anticipated Available Manufacturing 12/02/2025 tadalafil Tablet, film coated 20 mg Resolved Available Manufacturing 12/02/2025 hydrochlorothiazide~olmesartan medoxomil Tablet 12.5 mg~20 mg Current Unavailable Manufacturing 12/02/2025 dosulepin (dothiepin) hydrochloride Tablet, film coated 75 mg Current Limited Availability Manufacturing 12/02/2025 Trastuzumab Injection, powder for 156 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 12/02/2025 mefenamic acid Capsule, hard 250 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 12/02/2025 naloxone hydrochloride dihydrate Spray, nasal 2.2 mg/actuation Current Limited Availability Unexpected increase in consumer demand 12/02/2025 lurasidone hydrochloride Tablet, film coated 80 mg Current Unavailable Manufacturing 12/02/2025 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 12/02/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 109 mg Current Unavailable Manufacturing 12/02/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Current Unavailable Manufacturing 12/02/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 27.25 mg Current Unavailable Manufacturing 12/02/2025 midazolam Injection, solution 5 mg/mL Current Limited Availability Unexpected increase in consumer demand 12/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 12/02/2025 balsalazide sodium Capsule 750 mg Anticipated Available Manufacturing 12/02/2025 nizatidine Capsule 150 mg Anticipated Available Manufacturing 12/02/2025 exemestane Tablet, film coated 25 mg Current Limited Availability Manufacturing 11/02/2025 acetylcysteine Injection, concentrated 2 g Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 11/02/2025 armodafinil Tablet, uncoated 50 mg Anticipated Available Manufacturing 11/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 11/02/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~10.341 mg Current Unavailable Manufacturing 11/02/2025 Bevacizumab Injection, concentrated 25 mg/mL Current Unavailable Commercial Changes / Commercial viability 11/02/2025 mupirocin calcium Cream 21.5 mg/g Current Limited Availability Manufacturing 11/02/2025 ioversol Injection, solution 509 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 11/02/2025 ioversol Injection, solution 678 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 ioversol Injection, solution 678 mg/mL Discontinued Unavailable Unexpected increase in demand due to other sponsors unable to supply 11/02/2025 carboplatin Injection, solution 10 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 11/02/2025 ioversol Injection, solution 741 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 ioversol Injection, solution 678 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 ioversol Injection, solution 741 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 ioversol Injection, solution 741 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 ethinylestradiol~norethisterone Tablet, uncoated 36 microgram~500 microgram Anticipated Available Unexpected increase in consumer demand 11/02/2025 ioversol Injection, solution 678 mg/mL Discontinued Unavailable Manufacturing 11/02/2025 primidone Tablet, uncoated 250 mg Anticipated Available Manufacturing 10/02/2025 trihexyphenidyl (benzhexol) hydrochloride Tablet, uncoated 2 mg Anticipated Available Unexpected increase in consumer demand 10/02/2025 neostigmine methylsulfate Injection, solution 2.5 mg Current Unavailable Manufacturing 10/02/2025 ribociclib succinate Tablet, film coated 254.4 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 10/02/2025 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 10/02/2025 cisatracurium besilate Injection, solution 13.4 mg Anticipated Available Manufacturing 10/02/2025 pioglitazone hydrochloride Tablet, uncoated 16.53 mg Anticipated Available Commercial Changes / Commercial viability 10/02/2025 pioglitazone hydrochloride Tablet, uncoated 33.06 mg Anticipated Available Commercial Changes / Commercial viability 10/02/2025 oxycodone hydrochloride Oral Liquid, solution 1 mg/mL Resolved Available Unexpected increase in consumer demand 10/02/2025 dinoprostone Gel .6667 mg/g Resolved Available Manufacturing 10/02/2025 - 2025.02.10
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated paclitaxel Injection, concentrated 6 mg/mL Resolved Available Manufacturing 7/02/2025 colistimethate sodium Injection, powder for IU Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 7/02/2025 olanzapine Tablet, orally disintegrating 20 mg Anticipated Available Manufacturing 7/02/2025 levetiracetam Tablet, film coated 250 mg Current Unavailable Manufacturing 7/02/2025 capecitabine Tablet, film coated 500 mg Current Limited Availability Unexpected increase in consumer demand 7/02/2025 nicorandil Tablet 10 mg Anticipated Available Manufacturing 7/02/2025 ivabradine hydrochloride Tablet, film coated 5.39 mg Resolved Available Manufacturing 7/02/2025 fentanyl citrate Injection, solution 157 microgram Resolved Available Manufacturing 7/02/2025 fluorouracil Cream 50 mg/g Current Unavailable Manufacturing 7/02/2025 clindamycin phosphate Lotion 10 mg/mL Resolved Available Manufacturing 7/02/2025 ropivacaine hydrochloride~fentanyl citrate Injection, solution 2 mg/mL~6.28 microgram/mL Discontinued Unavailable Commercial Changes / Commercial viability 7/02/2025 ropivacaine hydrochloride~fentanyl citrate Injection, solution 2 mg/mL~6.28 microgram/mL Discontinued Unavailable Commercial Changes / Commercial viability 7/02/2025 citalopram hydrobromide Tablet, film coated 49.96 mg Anticipated Available Manufacturing 7/02/2025 carvedilol Tablet, film coated 6.25 mg Resolved Available Manufacturing 6/02/2025 ramipril Capsule, hard 1.25 mg Current Limited Availability Manufacturing 6/02/2025 octreotide Injection, solution 100 microgram Current Limited Availability Manufacturing 6/02/2025 octreotide Injection, solution 500 microgram Current Unavailable Manufacturing 6/02/2025 octreotide Injection, solution 50 microgram Current Limited Availability Manufacturing 6/02/2025 topiramate Tablet, film coated 200 mg Current Unavailable Manufacturing 6/02/2025 olanzapine Tablet, film coated 10 mg Current Limited Availability Manufacturing 6/02/2025 amisulpride Tablet 100 mg Current Limited Availability Manufacturing 6/02/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Anticipated Available Manufacturing 6/02/2025 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 6/02/2025 trandolapril Capsule, hard .5 mg Resolved Available Manufacturing 6/02/2025 trandolapril Capsule, hard 1 mg Current Unavailable Manufacturing 6/02/2025 trandolapril Capsule, hard 2 mg Current Unavailable Manufacturing 6/02/2025 trandolapril Capsule, hard 4 mg Current Unavailable Manufacturing 6/02/2025 risperidone Tablet, film coated 2 mg Current Unavailable Unexpected increase in consumer demand 6/02/2025 quetiapine fumarate Tablet, modified release 345.39 mg Anticipated Available Unexpected increase in consumer demand 6/02/2025 quetiapine fumarate Tablet, modified release 57.565 mg Anticipated Available Unexpected increase in consumer demand 6/02/2025 candesartan cilexetil Tablet, uncoated 4 mg Current Unavailable Manufacturing 6/02/2025 esomeprazole Capsule, enteric 40 mg Current Unavailable Manufacturing 6/02/2025 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 6/02/2025 dosulepin (dothiepin) hydrochloride Tablet, film coated 75 mg Anticipated Available Manufacturing 6/02/2025 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 6/02/2025 doxepin hydrochloride Capsule, hard 11.3 mg Current Limited Availability Manufacturing 6/02/2025 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 6/02/2025 atorvastatin calcium trihydrate Tablet, film coated 43.376 mg Current Limited Availability Manufacturing 6/02/2025 lamotrigine Tablet, chewable 100 mg Current Unavailable Unexpected increase in consumer demand 6/02/2025 levothyroxine sodium Tablet, uncoated 50 microgram Current Unavailable Manufacturing 6/02/2025 metformin hydrochloride Tablet, film coated 850 mg Current Limited Availability Manufacturing 6/02/2025 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 6/02/2025 alprostadil Injection, powder for 40 microgram/mL Current Unavailable Manufacturing 6/02/2025 nizatidine Capsule 150 mg Anticipated Available Manufacturing 6/02/2025 betiatide Injection, powder for 1 mg Current Unavailable Manufacturing 5/02/2025 acetylcholine chloride Solution, powder for irrigation 10 mg/mL Current Limited Availability Manufacturing 5/02/2025 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 5/02/2025 sugammadex sodium Injection, solution 217.6 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 5/02/2025 acetylcysteine Injection, concentrated 2 g Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 5/02/2025 nicotinic acid Tablet, uncoated 250 mg Resolved Available Manufacturing 5/02/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 5/02/2025 deferasirox Tablet, film coated 90 mg Anticipated Available Manufacturing 5/02/2025 melatonin Oral Liquid, solution 1 mg/mL Anticipated Available Unexpected increase in consumer demand 5/02/2025 carbidopa monohydrate~levodopa Tablet, uncoated 26.9 mg~100 mg Current Limited Availability Manufacturing 5/02/2025 imipramine hydrochloride Tablet, sugar coated 25 mg Current Unavailable Manufacturing 5/02/2025 norethisterone~ethinylestradiol Tablet, uncoated 1 mg~36 microgram Current Limited Availability Manufacturing 5/02/2025 citalopram hydrobromide Tablet, film coated 24.98 mg Current Limited Availability Manufacturing 5/02/2025 nizatidine Capsule 300 mg Resolved Available Manufacturing 5/02/2025 sodium pertechnetate(99mTc) Injection, solution 18.5 GBq Current Unavailable Manufacturing 4/02/2025 clonidine hydrochloride Tablet, uncoated 100 microgram Current Unavailable Transport / Logistic issues / Storage capacity issues 4/02/2025 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 4/02/2025 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Unavailable Manufacturing 4/02/2025 mesalazine Tablet, enteric coated 800 mg Current Limited Availability Manufacturing 4/02/2025 emtricitabine~tenofovir disoproxil fumarate Tablet, film coated 200 mg~300 mg Current Limited Availability Manufacturing 4/02/2025 Influenza virus haemagglutinin Injection, suspension 15 microgram Current Unavailable Seasonal depletion of stock 4/02/2025 mefenamic acid Capsule, hard 250 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 4/02/2025 nebivolol hydrochloride Tablet 5.45 mg Resolved Available Manufacturing 4/02/2025 Influenza virus haemagglutinin Injection, suspension 15 microgram Current Unavailable Seasonal depletion of stock 4/02/2025 albendazole Tablet, chewable 200 mg Resolved Available Manufacturing 4/02/2025 cisatracurium besilate Injection, solution 2.68 mg/mL Current Unavailable Manufacturing 4/02/2025 estradiol~norethisterone acetate Drug delivery system, transdermal .62 mg~2.7 mg Current Unavailable Manufacturing 4/02/2025 hydrocortisone acetate Eye Ointment 10 mg/g Resolved Available Manufacturing 3/02/2025 fentanyl Drug delivery system, transdermal 4.2 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/02/2025 tramadol hydrochloride Tablet, modified release 200 mg Resolved Available Manufacturing 3/02/2025 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 3/02/2025 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 3/02/2025 heparin sodium Injection, solution 25000 IU/mL Resolved Available Manufacturing 3/02/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.583 mg Current Unavailable Manufacturing 3/02/2025 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 10.396 mg~10 mg Current Limited Availability Manufacturing 3/02/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~20.791 mg Current Limited Availability Manufacturing 3/02/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~5.198 mg Current Limited Availability Manufacturing 3/02/2025 midazolam Injection, solution 5 mg Resolved Available Transport / Logistic issues / Storage capacity issues 3/02/2025 eftrenonacog alfa Injection, powder for 250 IU Resolved Available Unexpected increase in consumer demand 3/02/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 43.4 mg~10 mg Resolved Available Manufacturing 3/02/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 86.8 mg~10 mg Current Unavailable Manufacturing 3/02/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/02/2025 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~6.935 mg Resolved Available Manufacturing 3/02/2025 nebivolol hydrochloride Tablet 1.363 mg Current Unavailable Manufacturing 3/02/2025 clobazam Tablet, uncoated 10 mg Current Unavailable Manufacturing 3/02/2025 dasatinib propylene glycol Tablet, film coated 58 mg Current Unavailable Manufacturing 3/02/2025 dasatinib propylene glycol Tablet, film coated 81.2 mg Current Unavailable Manufacturing 3/02/2025 dasatinib propylene glycol Tablet, film coated 116 mg Current Unavailable Manufacturing 3/02/2025 nitrofurantoin Capsule, hard 100 mg Anticipated Available Manufacturing 3/02/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Current Unavailable Manufacturing 3/02/2025 carboplatin Injection, solution 10 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 3/02/2025 - 2025.02.03
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated Coxiella burnetii Injection 50 microgram/mL Resolved Available Manufacturing 31/01/2025 Coxiella burnetii Injection 5 microgram/mL Resolved Available Manufacturing 31/01/2025 carvedilol Tablet, film coated 6.25 mg Anticipated Available Manufacturing 31/01/2025 olanzapine pamoate monohydrate Injection, powder for 931 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 31/01/2025 olanzapine pamoate monohydrate Injection, powder for 690 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 31/01/2025 olanzapine pamoate monohydrate Injection, powder for 483 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 31/01/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Resolved Available Manufacturing 31/01/2025 fentanyl Drug delivery system, transdermal 8.4 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 31/01/2025 galantamine hydrobromide Capsule, modified release 10.252 mg Current Unavailable Manufacturing 31/01/2025 galantamine hydrobromide Capsule, modified release 20.504 mg Current Unavailable Manufacturing 31/01/2025 azithromycin dihydrate Tablet, film coated 524.05 mg Current Unavailable Manufacturing 31/01/2025 trandolapril Capsule, hard .5 mg Current Limited Availability Manufacturing 31/01/2025 quetiapine fumarate Tablet, modified release 172.695 mg Anticipated Available Unexpected increase in consumer demand 31/01/2025 quetiapine fumarate Tablet, modified release 57.565 mg Anticipated Available Unexpected increase in consumer demand 31/01/2025 quetiapine fumarate Tablet, film coated 28.78 mg Current Unavailable Manufacturing 31/01/2025 metoprolol succinate Tablet, modified release 95 mg Current Limited Availability Manufacturing 31/01/2025 raloxifene hydrochloride Tablet, film coated 60 mg Current Unavailable Unexpected increase in consumer demand 31/01/2025 docetaxel Injection, concentrated 80 mg Resolved Available Manufacturing 31/01/2025 candesartan cilexetil Tablet, uncoated 4 mg Current Limited Availability Manufacturing 31/01/2025 escitalopram oxalate Tablet, film coated 12.74 mg Resolved Available Transport / Logistic issues / Storage capacity issues 31/01/2025 citalopram hydrobromide Tablet, film coated 49.98 mg Current Unavailable Manufacturing 31/01/2025 buprenorphine Drug delivery system, transdermal 5 mg Resolved Available Transport / Logistic issues / Storage capacity issues 31/01/2025 azithromycin dihydrate Tablet, film coated 524 mg Resolved Available Manufacturing 31/01/2025 tenofovir disoproxil maleate~emtricitabine Tablet, film coated 300 mg~200 mg Current Limited Availability Manufacturing 31/01/2025 irbesartan~hydrochlorothiazide Tablet, film coated 300 mg~12.5 mg Current Limited Availability Manufacturing 31/01/2025 hydrochlorothiazide~irbesartan Tablet, film coated 25 mg~300 mg Current Unavailable Manufacturing 31/01/2025 tadalafil Tablet, film coated 20 mg Current Unavailable Manufacturing 31/01/2025 ivabradine hydrochloride Tablet, film coated 5.39 mg Current Limited Availability Manufacturing 31/01/2025 cisplatin Injection, concentrated 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 31/01/2025 pregabalin Capsule, hard 25 mg Current Unavailable Manufacturing 31/01/2025 olanzapine Tablet, uncoated 2.5 mg Resolved Available Manufacturing 31/01/2025 levothyroxine sodium Tablet, uncoated .05 mg Anticipated Available Unexpected increase in consumer demand 31/01/2025 gentamicin sulfate Injection, solution 135.6 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 31/01/2025 tamoxifen citrate Tablet, uncoated 15.2 mg Current Limited Availability Manufacturing 31/01/2025 levodopa~carbidopa monohydrate Tablet, uncoated 100 mg~26.9 mg Current Limited Availability Manufacturing 31/01/2025 cabergoline Tablet, uncoated 1 mg Resolved Available Manufacturing 31/01/2025 midazolam Injection, solution 5 mg/mL Anticipated Available Unexpected increase in consumer demand 31/01/2025 metformin hydrochloride Tablet, film coated 500 mg Resolved Available Manufacturing 31/01/2025 reboxetine mesilate Tablet, uncoated 5.224 mg Current Limited Availability Manufacturing 31/01/2025 prazosin hydrochloride Tablet, uncoated 2.19 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 30/01/2025 fludarabine phosphate Injection, concentrated 50 mg Resolved Available Manufacturing 30/01/2025 sodium fluoride Injection, concentrated 1 mg/mL Current Unavailable Manufacturing 30/01/2025 olmesartan medoxomil~hydrochlorothiazide~amlodipine besilate Tablet 40 mg~25 mg~6.944 mg Current Limited Availability Manufacturing 30/01/2025 eftrenonacog alfa Injection, powder for 250 IU Current Unavailable Unexpected increase in consumer demand 30/01/2025 cyclopentolate hydrochloride Eye Drops, solution 10 mg/mL Resolved Available Manufacturing 30/01/2025 ropivacaine hydrochloride monohydrate Injection, solution 2.116 mg/mL Current Unavailable Commercial Changes / Commercial viability 30/01/2025 metformin hydrochloride Tablet, film coated 1000 mg Anticipated Available Manufacturing 30/01/2025 cisplatin Injection, concentrated 1 mg/mL Current Limited Availability Manufacturing 30/01/2025 encorafenib Capsule, hard 75 mg Resolved Available Manufacturing 30/01/2025 estradiol Drug delivery system, transdermal .39 mg Current Limited Availability Manufacturing 30/01/2025 estradiol hemihydrate Tablet, film coated 2.06 mg Anticipated Available Manufacturing 30/01/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Resolved Available Unexpected increase in consumer demand 30/01/2025 testosterone enantate Injection 250 mg/mL Resolved Available Unexpected increase in consumer demand 29/01/2025 clozapine Oral Liquid, suspension 50 mg/mL Current Unavailable Manufacturing 29/01/2025 pentetic acid Injection, powder for 5 mg Current Emergency Supply Only Manufacturing 29/01/2025 medronic acid Injection, powder for 10 mg Current Unavailable Manufacturing 29/01/2025 rizatriptan benzoate Wafer 14.53 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 29/01/2025 epirubicin hydrochloride Injection, concentrated 200 mg Current Unavailable Manufacturing 29/01/2025 Follitropin alfa Injection, solution 150 IU Anticipated Available Manufacturing 29/01/2025 benzatropine mesilate Injection 1 mg/mL Resolved Available Manufacturing 29/01/2025 clonazepam Tablet, uncoated .5 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 29/01/2025 buprenorphine Patch, dermal 30 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 29/01/2025 oxaliplatin Injection, concentrated 100 mg Current Limited Availability Manufacturing 29/01/2025 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Resolved Available Unexpected increase in consumer demand 29/01/2025 tobramycin Injection, solution 80 mg Current Unavailable Manufacturing 28/01/2025 salbutamol sulfate Inhalation, conventional 3 mg Current Unavailable Manufacturing 28/01/2025 sodium pyrophosphate Injection, powder for 30 mg Current Unavailable Manufacturing 28/01/2025 trihexyphenidyl (benzhexol) hydrochloride Tablet, uncoated 5 mg Current Limited Availability Unexpected increase in consumer demand 28/01/2025 omega3acid ethyl esters 90 Capsule, soft 1000 mg Anticipated Available Manufacturing 28/01/2025 oxytocin Injection, solution 10 IU Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/01/2025 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Resolved Available Manufacturing 28/01/2025 clonidine hydrochloride Tablet, uncoated 100 microgram Current Limited Availability Transport / Logistic issues / Storage capacity issues 28/01/2025 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 28/01/2025 quetiapine fumarate Tablet, modified release 460.52 mg Current Limited Availability Manufacturing 28/01/2025 quetiapine fumarate Tablet, film coated 28.78 mg Resolved Available Manufacturing 28/01/2025 midazolam Injection, solution 5 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 28/01/2025 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 28/01/2025 duloxetine hydrochloride Capsule, enteric 67.32 mg Resolved Available Commercial Changes / Commercial viability 28/01/2025 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Unavailable Manufacturing 28/01/2025 tranexamic acid Injection, solution 100 mg/mL Resolved Available Manufacturing 28/01/2025 cisatracurium besilate Injection, solution 14.07 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 28/01/2025 amiodarone hydrochloride Injection, solution 150 mg Anticipated Available Manufacturing 28/01/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in consumer demand 28/01/2025 mupirocin Ointment 20 mg/g Current Limited Availability Unexpected increase in consumer demand 28/01/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 28/01/2025 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 28/01/2025 risperidone Tablet, film coated 2 mg Current Unavailable Manufacturing 28/01/2025 risperidone Tablet, film coated 3 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 28/01/2025 risperidone Tablet, film coated 4 mg Current Unavailable Manufacturing 28/01/2025 pregabalin Capsule, hard 75 mg Current Unavailable Unexpected increase in consumer demand 28/01/2025 dimethyl fumarate Capsule, enteric 120 mg Current Limited Availability Manufacturing 28/01/2025 tamoxifen citrate Tablet 30.34 mg Current Limited Availability Manufacturing 28/01/2025 levothyroxine sodium Tablet .05 mg Current Unavailable Manufacturing 28/01/2025 levothyroxine sodium Tablet .2 mg Current Unavailable Manufacturing 28/01/2025 levothyroxine sodium Tablet .1 mg Current Unavailable Manufacturing 28/01/2025 levothyroxine sodium Tablet .075 mg Current Unavailable Manufacturing 28/01/2025 olanzapine Tablet, uncoated 5 mg Anticipated Available Manufacturing 28/01/2025
ドイツ
- 2025.02.25
Active ingredients Message type Date of the last message Type of reason Prednisolone acetate Change notification 21.02.2025 Production problem Levomethadone hydrochloride Change notification 21.02.2025 Other Aprepitant Change notification 21.02.2025 Other Trimipramine mesilate Change notification 21.02.2025 Other Sodium valproate; valproic acid Change notification 21.02.2025 Other Clarithromycin Change notification 21.02.2025 Other Azithromycin dihydrate Change notification 21.02.2025 Other Linezolid Change notification 21.02.2025 Other Hydromorphone hydrochloride Change notification 21.02.2025 Other Ciprofloxacin hydrochloride (1:1) 1 H<2>O Change notification 21.02.2025 Other Oseltamivir phosphate Initial notification 21.02.2025 Other Ezetimibe; Simvastatin Change notification 21.02.2025 Production problem Rizatriptan benzoate Change notification 21.02.2025 Production problem Protamine sulphate ((with details of production and sulphuric acid content)) Initial notification 21.02.2025 Production problem Quetiapine fumarate (Ph.Eur.) Change notification 21.02.2025 Production problem Cabergoline Change notification 21.02.2025 Other Betamethasone valerate (Ph.Eur.) Initial notification 21.02.2025 Other Flunisolide hemihydrate Initial notification 20.02.2025 Other Teicoplanin Change notification 20.02.2025 Other Framycetin sulphate (1:x) ((with details of sulphuric acid content)); lidocaine hydrochloride monohydrate Initial notification 20.02.2025 Production problem Buprenorphine Change notification 20.02.2025 Other Methylphenidate hydrochloride Initial notification 20.02.2025 Other Tacrolimus monohydrate Change notification 20.02.2025 Other Carbamazepine Initial notification 20.02.2025 Other Hydromorphone hydrochloride Change notification 20.02.2025 Other Oxycodone hydrochloride (Ph.Eur.) Change notification 20.02.2025 Other Metoprolol tartrate (Ph.Eur.) Change notification 20.02.2025 Other Oxazepam Change notification 20.02.2025 Other Methyldopa (Ph.Eur.) Change notification 20.02.2025 Production problem Amoxicillin trihydrate Change notification 20.02.2025 Other Esmolol hydrochloride Initial notification 19.02.2025 Production problem Prednisolone Initial notification 19.02.2025 Other Spironolactone Initial notification 19.02.2025 Production problem Gentamicin sulphate Change notification 19.02.2025 Production problem Cefaclor monohydrate Change notification 19.02.2025 Other Iobenguan ((123)I) Initial notification 19.02.2025 Production problem Biperidene hydrochloride Initial notification 18.02.2025 Production problem Isosorbide mononitrate Change notification 18.02.2025 Production problem Pramipexole dihydrochloride monohydrate Change notification 18.02.2025 Production problem Cytarabine Change notification 18.02.2025 Production problem Terbutaline sulphate (Ph.Eur.) Initial notification 18.02.2025 Other Tobramycin Change notification 18.02.2025 Production problem Fluticasone propionate (Ph.Eur.) Change notification 17.02.2025 Other Duloxetine hydrochloride Initial notification 17.02.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 17.02.2025 Other Aprepitant Initial notification 17.02.2025 Production problem Articaine hydrochloride Initial notification 17.02.2025 Other - 2025.02.17
Active ingredients Message type Date of the last message Type of reason Solifenacin succinate Initial notification 14.02.2025 Other Hydrocortisone-17-butanoate Initial notification 14.02.2025 Other Cyclopentolate hydrochloride Initial notification 14.02.2025 Production problem Methyldopa (Ph.Eur.) Initial notification 14.02.2025 Production problem Quetiapine fumarate (Ph.Eur.) Change notification 13.02.2025 Other Fludarabine phosphate (Ph.Eur.) Initial notification 13.02.2025 Production problem Dacarbazine citrate Initial notification 13.02.2025 Production problem Carbamazepine Change notification 13.02.2025 Other Fluorouracil Change notification 13.02.2025 Other Phenytoin Change notification 13.02.2025 Other Hydromorphone hydrochloride Initial notification 13.02.2025 Other Sodium mucophenolate Initial notification 13.02.2025 Other Domperidone Change notification 12.02.2025 Production problem Quetiapine fumarate (Ph.Eur.) Change notification 12.02.2025 Other Moxifloxacin hydrochloride (Ph.Eur.) ((with details of water content (1:x))) Change notification 12.02.2025 Production problem Solifenacin succinate Initial notification 12.02.2025 Other Hydromorphone hydrochloride Initial notification 12.02.2025 Production problem Phenoxymethylpenicillin potassium Change notification 12.02.2025 Production problem Morphine sulphate (Ph.Eur.) Change notification 12.02.2025 Other Hydromorphone hydrochloride Initial notification 12.02.2025 Other Aprepitant Initial notification 12.02.2025 Other Methyldopa (Ph.Eur.) Change notification 12.02.2025 Production problem Itraconazole Change notification 11.02.2025 Other Clarithromycin Change notification 11.02.2025 Other Sultiam Initial notification 11.02.2025 Other Doxepin hydrochloride (Ph.Eur.) Change notification 11.02.2025 Other Baclofen Change notification 11.02.2025 Other Sultiam Initial notification 11.02.2025 Other Pramipexole dihydrochloride monohydrate Change notification 11.02.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 11.02.2025 Other Solifenacin succinate Initial notification 11.02.2025 Other Ethambutol dihydrochloride Initial notification 11.02.2025 Production problem Rifampicin sodium Initial notification 11.02.2025 Production problem Solifenacin succinate Initial notification 11.02.2025 Production problem Aprepitant Initial notification 11.02.2025 Other Lamotrigine Change notification 11.02.2025 Production problem Hydromorphone hydrochloride Initial notification 10.02.2025 Other Quetiapine fumarate (Ph.Eur.) Initial notification 10.02.2025 Production problem Solifenacin succinate Initial notification 10.02.2025 Other Naltrexone hydrochloride Initial notification 10.02.2025 Production problem Aprepitant Initial notification 10.02.2025 Production problem Fluticasone propionate (Ph.Eur.) Initial notification 10.02.2025 Other - 2025.02.10
Active ingredients Message type Date of the last message Type of reason Olanzapine Change notification 09.02.2025 Production problem Pramipexole dihydrochloride monohydrate Initial notification 07.02.2025 Other Amoxicillin trihydrate Change notification 07.02.2025 Other Carboplatin Change notification 07.02.2025 Other Doxorubicin hydrochloride Change notification 07.02.2025 Other Aprepitant Initial notification 07.02.2025 Other Proxymetacaine hydrochloride Initial notification 07.02.2025 Production problem Moxifloxacin hydrochloride (Ph.Eur.) ((with information on water content (1:x))) Initial notification 06.02.2025 Other ofloxacin Initial notification 06.02.2025 Production problem Paliperidone palmitate Initial notification 06.02.2025 Other Insulin aspart Initial notification 06.02.2025 Production problem Paliperidone palmitate Initial notification 06.02.2025 Other Carbamazepine Change notification 06.02.2025 Other Urapidil Change notification 06.02.2025 Other Hydromorphone hydrochloride Change notification 06.02.2025 Other Hydrocortisone Change notification 06.02.2025 Other Insulin glargine Initial notification 05.02.2025 Other Salbutamol sulfate Change notification 05.02.2025 Other Aprepitant Initial notification 05.02.2025 Other Cyclophosphamide monohydrate Change notification 05.02.2025 Other Tacrolimus monohydrate Initial notification 05.02.2025 Other Betamethasone valerate (Ph.Eur.) Initial notification 05.02.2025 Other Mometasone furoate (Ph.Eur.) Initial notification 05.02.2025 Other Hydrocortisone Initial notification 05.02.2025 Other Betamethasone dipropionate (Ph.Eur.); gentamicin sulphate Initial notification 05.02.2025 Other Rotigotine Initial notification 04.02.2025 Other Cytarabine Initial notification 04.02.2025 Production problem Oxycodone hydrochloride Initial notification 04.02.2025 Other Moxifloxacin hydrochloride (Ph.Eur.) ((with information on water content (1:x))) Initial notification 04.02.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 04.02.2025 Other Quetiapine fumarate (Ph.Eur.) Initial notification 03.02.2025 Production problem Azithromycin dihydrate Initial notification 03.02.2025 Other Carbamazepine Change notification 03.02.2025 Production problem Azithromycin dihydrate Change notification 03.02.2025 Other Medroxyprogesterone acetate Change notification 03.02.2025 Other Galantamine hydrobromide Change notification 03.02.2025 Production problem Quetiapine fumarate (Ph.Eur.) Change notification 03.02.2025 Production problem Amlodipine besylate; perindopril tert-butylamine Change notification 03.02.2025 Production problem Dexamethasone; gentamicin sulphate Change notification 03.02.2025 Production problem - 2025.02.03
Active ingredients Message type Date of the last message Type of reason Moxifloxacin hydrochloride (Ph.Eur.) ((with details of water content (1:x))) Initial notification 01.02.2025 Production problem Linezolid Change notification 31.01.2025 Other Trihexyphenidyl hydrochloride Change notification 31.01.2025 Production problem Fibrinogen from humans Change notification 31.01.2025 Other Morphine sulphate (Ph.Eur.) Initial notification 31.01.2025 Other Oxycodone hydrochloride (Ph.Eur.) Initial notification 31.01.2025 Other Morphine sulphate (Ph.Eur.) Change notification 31.01.2025 Other Fluorouracil Initial notification 31.01.2025 Other Teicoplanin Change notification 31.01.2025 Other Teicoplanin Change notification 31.01.2025 Other Nonacog beta pegol Initial notification 31.01.2025 Other Eptacog alfa (activated) Initial notification 31.01.2025 Other Tranexamic acid Initial notification 31.01.2025 Other Fluorouracil Change notification 31.01.2025 Other Moxifloxacin hydrochloride (Ph.Eur.) ((with details of water content (1:x))) Initial notification 31.01.2025 Production problem Acemetacin Initial notification 30.01.2025 Other Nonacog gamma Initial notification 30.01.2025 Production problem Cefaclor monohydrate Initial notification 30.01.2025 Other Sultamicillin tosilate dihydrate Initial notification 30.01.2025 Other Atomoxetine hydrochloride Change notification 29.01.2025 Production problem Etoposide Change notification 29.01.2025 Production problem Doxycycline hyclate Change notification 29.01.2025 Other Pramipexole dihydrochloride monohydrate Change notification 29.01.2025 Other Raloxifene hydrochloride Change notification 29.01.2025 Other Quetiapine fumarate (Ph.Eur.) Initial notification 29.01.2025 Other Indapamide hemihydrate Initial notification 29.01.2025 Production problem Primidone Initial notification 29.01.2025 Other Levetiracetam Change notification 29.01.2025 Production problem Phenytoin Change notification 29.01.2025 Other Oxazepam Change notification 29.01.2025 Other Carbamazepine Change notification 29.01.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 28.01.2025 Other Trimipramine mesilate Change notification 28.01.2025 Other Levomethadone hydrochloride Change notification 28.01.2025 Other Paliperidone palmitate Initial notification 28.01.2025 Production problem Paliperidone palmitate Initial notification 28.01.2025 Production problem Levetiracetam Change notification 28.01.2025 Other Risperidone Change notification 28.01.2025 Production problem Cinacalcethydrochloride Change notification 28.01.2025 Other Azithromycin dihydrate Change notification 28.01.2025 Other Hydromorphone hydrochloride Change notification 28.01.2025 Other Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) Change notification 27.01.2025 Other Moxifloxacin hydrochloride (Ph.Eur.) ((with details of water content (1:x))) Change notification 27.01.2025 Other Doxorubicin hydrochloride Initial notification 27.01.2025 Production problem Triamcinolone acetonide Initial notification 27.01.2025 Other
フランス
- 2025.02.25
Ingredients Status Update Specialty naloxegol (oxalate) Supply tension 21/02/2025 Moventig 12.5 mg, film-coated tablet – naloxegol (oxalate) Out of stock 21/02/2025 Moventig 25 mg, film-coated tablet – methylprednisolone (sodium hydrogen succinate) Supply tension 21/02/2025 Methylprednisolone Hikma 40 mg, powder for injectable solution – methylphenidate (hydrochloride) Supply tension 20/02/2025 Medikinet 30 mg, modified-release capsule – calcium levofolinate Marketing discontinued 20/02/2025 Elvorine 25 mg/2.5 ml, 50 mg/5 ml, 100 mg/10 ml and 175 mg/17.5 ml, solution for injection – methylphenidate (hydrochloride) Supply voltage 20/02/2025 Methylphenidate EG LP 18 mg and 54 mg, extended-release tablet – emtricitabine/tenofovir disoproxil Supply tension 20/02/2025 Speciality based on emtricitabine/tenofovir disoproxil 200 mg/245 mg, film-coated tablet – tetracosactide Supply tension 18/02/2025 Synacthene 0.25 mg/1 ml, solution for injection – alfacalcidol Supply tension 18/02/2025 Un-Alfa 0.50 microgram, soft capsule – poractant alfa Availability 18/02/2025 Curosurf, suspension for endotracheobronchial instillation – calcium (chloride) dihydrate, lactic acid, magnesium (chloride) hexahydrate, sodium (bicarbonate), sodium (chloride) Out of stock 17/02/2025 Hemosol B0, solution for hemodialysis/hemofiltration – methylphenidate (hydrochloride) Supply tension 17/02/2025 Concerta LP, extended-release tablet – tiapride (hydrochloride) Out of stock 17/02/2025 Tiapridal 100 mg/2 ml, solution for injection – methylprednisolone (hydrogen succinate) Out of stock 17/02/2025 Methylprednisolone Viatris 40 mg, powder for solution for injection (IM-IV) – linezolid Supply tension 17/02/2025 Linezolid 600 mg, film-coated tablet – levodopa – carbidopa Available again 17/02/2025 Levodopa Carbidopa Teva 250 mg/25 mg, scored tablet – methylprednisolone (hydrogen succinate) Supply tension 17/02/2025 Methylprednisolone Viatris 20 mg, powder for solution for injection (IM-IV) – - 2025.02.17
Ingredients Status Update Specialty phenobarbital sodium Supply tension 14/02/2025 Gardenal 200 mg/4 ml, powder and solvent for solution for injection – bevacizumab Remise à disposition 14/02/2025 Aybintio 25 mg/ml, solution for diluted infusion (16 ml bottle) – peginterferon alfa-2a Supply tension 13/02/2025 Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringes – acarbose Remise à disposition 13/02/2025 Acarbose 50 mg (specialties based on) – menotropin Available again 13/02/2025 Menopur 75 IU/ml, powder and solvent for solution for injection – methylprednisolone (hydrogen succinate) Supply tension 13/02/2025 Methylprednisolone Viatris 40 mg, powder for solution for injection (IM-IV) – colchicine, opium (powder), tiemonium (metilsulfate) Supply tension 12/02/2025 Colchimax, scored film-coated tablet and Colchicine Opocalcium 1 mg, scored tablet – diltiazem (hydrochloride) Out of stock 12/02/2025 Bi Tildiem L.P. 120 mg, sustained-release coated tablet – glutamic acid, calcium (chloride) dihydrate, glutathione, histidine, lactobionic acid, magnesium (chloride) hexahydrate, mannitol, potassium (chloride), sodium (hydroxide) Supply tension 12/02/2025 Celsior, solution for organ preservation – bromfenac sodium sesquihydrate Remise à disposition 12/02/2025 Yellox 0.9 mg/ml, eye drops solution – calcium heparin Supply tension 12/02/2025 Calcium heparin 25,000 IU/mL, solution for injection in pre-filled syringes (S.C.) of 0.2 mL and 0.3 mL, Calciparin 5,000 IU/0.2 mL and 7,500 IU/0.3 mL, solution for injection in pre-filled syringes (S.C.) – heparin calcium Supply tension 12/02/2025 Heparin calcium Panpharma 25 000 IU/mL, solution for injection in pre-filled syringes (S.C.) of 0.2 mL, 0.3 ml and solution for injection in ampoule 0.5 ml – levothyroxine Marketing discontinuation 11/02/2025 Tsoludose, solution buvable en récipient unidose – lenalidomide Supply tension 11/02/2025 lenalidomide Mylan, capsule – baclofène Supply tension 10/02/2025 Baclofen EG 10 mg, scored tablet – baclofène Supply tension 10/02/2025 Baclofène Zentiva 10 mg, scored tablet – - 2025.02.10
Ingredients Status Update Specialty poractant alfa Supply tension 07/02/2025 Curosurf, suspension for endotracheobronchial instillation – disopyramide (phosphate) Supply tension 07/02/2025 Rythmodan 250 mg sustained-release, coated tablet – etoposide Out of stock 07/02/2025 Etoposide Accord 20 mg/ml, dilutable solution for infusion – paliperidone Supply tension 06/02/2025 Xeplion, prolonged-release suspension for injection – acetazolamide Supply tension 06/02/2025 Diamox 250 mg, scored tablet – levofloxacin Supply tension 06/02/2025 Specialties based on Levofloxacin 500 mg scored film-coated tablet – icatibant (acetate) Remise à disposition 05/02/2025 Icatibant Viatris 30 mg, solution for injection in pre-filled syringe – risperidone Supply tension 05/02/2025 Risperidone 0.5 mg, 1 mg, 2 mg 3 mg and 4 mg orodispersible tablet – triamcinolone (acetonide of) Available for use 04/02/2025 Kenacort Retard 40 mg/1 ml, suspension for injection – diltiazem (hydrochloride) Supply tension 03/02/2025 Bi Tildiem L.P. 90 mg, sustained-release coated tablet – etoposide Supply tension 03/02/2025 Etoposide Teva, solution for infusion – - 2025.02.03
Ingredients Status Update Specialty fluoroestradiol (18F) Supply tension 31/01/2025 Estrotep 500 MBq/mL, solution for injection – sodium clodronate anhydrous Supply tension 31/01/2025 Lytos 520 mg, film-coated tablet – calcium (carbonate) Supply tension 31/01/2025 Calcidia 1.54 g, granulated oral suspension in dose sachet – lenalidomide Supply tension 31/01/2025 Lenalidomide Mylan, capsule – clofazimine Available again 31/01/2025 Lamprene 100 mg, soft capsule – quetiapine (fumarate of) Supply tension 30/01/2025 Quetiapine LP (Xeroquel LP) 50 mg, 300 mg and 400 mg Prolonged-release tablet – rifampicin Supply tension 29/01/2025 Rifadine 2%, drinkable suspension – isoniazid, rifampin Supply tension 29/01/2025 Rifinah 300 mg/150 mg, coated tablet – isoniazid, pyrazinamid, rifampicin Supply tension 29/01/2025 Rifater, Coated tablet – somatotropin Available again 29/01/2025 Genotonorm 12 mg, powder and solvent for solution for injection box of 5 cartridges in GoQuick pre-filled pen – rifampicin Supply tension 29/01/2025 Rifadine 300 mg, capsule – rifampicin Supply tension 29/01/2025 Rifadine IV 600 mg, powder and solvent for solution for infusion – methylphenidate (hydrochloride) Handover 29/01/2025 Methylphenidate Biogaran LP, extended-release tablet – Supply tension 29/01/2025 Exacyl 500 mg, film-coated tablet – (tranexamic acid) daptomycin Out of stock 29/01/2025 Daptomycin Noridem 500 mg, powder for solution for injection/infusion in 10 ml vial – magnesium (pidolate of) Supply tension 28/01/2025 Maginjectable 0.8 per cent, solution for injection – emtricitabine/tenofovir disoproxil Supply tension 28/01/2025 Speciality based on emtricitabine/tenofovir disoproxil 200 mg/245 mg, film-coated tablet – Iobenguane (¹³¹I) Marketing discontinuation 28/01/2025 Iobenguane (¹³¹I) for therapy CIS bio international 370 MBq/mL, solution for infusion – spiramycin (adipate) Availability 27/01/2025 Rovamycin 1.5 million international units, lyophilisate for parenteral use – oseltamivir Supply tension 27/01/2025 Tamiflu 75 mg, capsule –
英国
- 2025.02.25
医薬品供給通知:酢酸トリプトレリン(ゴナペプチル®デポ)3.75mg粉末および注射用懸濁液用溶媒プレフィルドシリンジ
このトリプトレリンのプレゼンテーションは2026年1月まで利用できないという発表ですが、代替のゴナドトロピン放出ホルモン類似体は引き続き利用可能です。
出典:Community Pharmacy Englandクラス3の医薬品のリコール:グルコファージSR 500mg、750mg、1000mgの徐放性錠剤、EL(25)A/07
この製品の一部のバッチは、イタリアの販売承認保有者によってリコールされ、その後、一部の英国の並行販売会社によってリコールされています。これは、ヒドロキシプロピルメチルセルロースのグレードが正しく含まれていないためです。 - 2025.02.18
医薬品供給通知:クエチアピン50mg、150mg、200mg、300mg、400mgの徐放性錠剤
リストされている強度に影響を与える供給制約があります。クエチアピン即時放出錠剤は引き続き利用可能であり、需要の増加をサポートできます。これらが適切でない場合は、クエチアピン徐放性錠剤の無認可の供給を調達する可能性があり、リードタイムは異なります。.
出典:Community Pharmacy England
局所乾癬治療薬の入手可能性の更新
Diprosalic scalp application (betamethasone)、Metosyn (フルオシノニド 0.05%) クリーム、Cocois 軟膏 100g チューブ (コールタール/硫黄/サリチル酸)、Psoriderm クリーム (コールタール)、Ceanel 濃縮シャンプー (セトリマイド/ウンデセン酸) に関する最新情報。
出典:Monthly Index of Medical Specialities
- 2025.02.04
医薬品供給通知:メマンチン(Valios®)5mg口腔内崩壊錠無糖
この特定のメマンチン製剤は2025年4月下旬まで在庫切れであるという通知。メマンチン10mg / mL経口溶液、5mg / 0.5mLポンプ作動経口溶液、およびフィルムコーティングおよび口腔内崩壊性製剤の両方として10および20mgの強度錠剤が引き続き利用可能です。.
出典:Community Pharmacy England
EU
EUの情報はありません。